Xceed Molecular licenses gene analysis chip tech to Gen-Probe

By Mass High Tech Staff

Xceed licenses colon cancer test tech [June 10, 2008]

Foundation Medicine, Dana-Farber tout cancer finding [February 13, 2012]

OncoPep licenses cancer vaccine, moves to add $500K to Series A [February 13, 2012]

Oxford Immunotec taps Altieri as CFO [February 13, 2012]

Xceed Molecular, a Canadian firm with offices in Wellesley, says it has granted Gen-Probe Inc. a non-exclusive license to use Xceed’s Flow-Thru Chip technology for gene analysis.

According to officials at San Diego-based Gen-Probe (Nasdaq: GPRO), the company will incorporate the Xceed technology into its molecular-diagnostics products. Gen-Probe is a maker of nucleic acid testing products for diagnosing human diseases and screening donated human blood.

No financial details of the agreement were released, but officials said Gen-Probe will pay unspecified up-front licensing and milestone fees to Xceed for the Flow-Thru Chip technology in specific fields. Gen-Probe also has the right to obtain co-exclusive rights with Xceed in pre-defined sub-fields.

Xceed’s R&D and manufacturing facilities are based in Toronto, with executive offices in Wellesley.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.